To investigate the potential involvement of SphK2 in regorafenib resistance, five HCC cell lines were used, namely, BEL-7402, HuH-7, PLC/PRF/5, SMMC-7721, and MHCC97H. This evidence concerns the gene SPHK2 and hepatocellular carcinoma.